Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Use of akatinol memantine for the treatment of Korsakoff's syndrome: a clinical case

https://doi.org/10.14412/2074-2711-2020-6-124-130

Full Text:

Abstract

Approaches to treating cognitive-amnestic disorders of various origins, including Korsakoff's syndrome (KS), are currently being actively elaborated. KS is manifested by severe memory impairment, leading to disability. It is quite common in alcohol abusers. There is still no proven effective treatment for KS. In view of the fact that studies on the treatment of KS have been very few, there are no clear recommendations for its most effective treatment. There has been evidence that in addition to thiamine deficiency, the toxic effect of glutamate that is actively released through binding to NMDA receptors during the ethanol withdrawal period is the basis for KS development. Memantine, a noncompetitive NMDA receptor antagonist, has recently been used successfully to treat KS. The paper describes a clinical case of a 55-year-old patient with KS treated with akatinol memantine, in which the latter has demonstrated its high efficacy and good tolerance. Analysis of the data available in the literature and the presented clinical case suggest that it is advisable to prescribe memantine for patients with alcohol-related memory impairment.

About the Authors

N. A. Tyuvina
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation

11, Rossolimo St., Build. 9, Moscow 119021



T. N. Maksimova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation

11, Rossolimo St., Build. 9, Moscow 119021



S. V. Prokhorova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation

Svetlana Vladimirovna Prokhorova

Department of Psychiatry and Narcology

11, Rossolimo St., Build. 9, Moscow 119021



V. O. Vysokova
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia
Russian Federation

11, Rossolimo St., Build. 9, Moscow 119021



References

1. Korsakov SS. Uchenie o korsakovskom psihoze [The doctrine of Korsakov's psychosis]. In: Selected works. Ed. by V.M. Banshhikov, E.A. Popov. Moscow: State publishing house of med. liter.; 1954. P. 263-425 (In Russ.).

2. Bukanovskaya TI, Dzaparova LK. Subclinical stage in the development of Korsakov's syndrome: neuropsychological and electromyographic correlations. Mezhdunarodnyy nauchno-issledovatel'skiy zhurnal = International Research Journal. 2018;3(69):105-11. doi: 10.23670/IRJ.2018.69.011 (In Russ.).

3. Sullivan EV, Fama R. Wernicke's encephalopathy and Korsakoff's syndrome revisited. Neuropsychol Rev. 2012;22(2):69-71. doi: 10.1007/s11065-012-9205-2

4. Sivolap YuP, Damulin IV. Wernicke's encephalopathy and Korsakov's psychosis: clinical and pathogenetic relationships, diagnosis and treatment. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Spetsvypuski. 2013;113(6):20-6 (In Russ.).

5. Harper C, Fornes P, Duyckaerts C, et al. An international perspective on the prevalence of the Wernicke-Korsakoff syndrome. Metab Brain Dis. 1995 Mar;10(1):17-24. doi: 10.1007/BF01991779

6. Torvik A, Lindboe CF, Rogde S. Brain lesions in alcoholics. A neuropathological study with clinical correlations. J Neurol Sci. 1982 Nov;56(2-3):233-48. doi: 10.1016/0022-510x(82)90145-9

7. Sivolap YuP. Alcoholic brain disease: pathogenesis, clinical forms, modern approach to treatment. Consilium Medicum. 2008;(2):43-9 (In Russ.).

8. Wedisinghe L, Jayakody K, Arambage K. Wernicke's encephalopathy: a preventable cause of maternal death. Br J Hosp Med (Lond). 2011 Jan;72(1):31-4. doi: 10.12968/hmed.2011.72.1.31

9. Arts NJM, Walvoort SJW, Kessels RPC. Korsakoff's syndrome: a critical review. Neuropsychiatr Dis Treat. 2017;13:2875-90. doi:10.2147/NDT.S130078

10. Khokhlov LK, Khokhlov AL. Exogenous organic psychopathology: neurosis-like states, acute, protracted symptomatic psychoses, psychoorganic syndromes. In: Terapiya kognitivnykh rasstroystv: Monografiya [Therapy of cognitive disorders: monograph]. Yaroslavl: LLC «Photolife»; 2019. P. 354-413 (In Russ.).

11. Fujiwara E, Brand M, Borsutzky S, et al. Cognitive performance of detoxified alcoholic Korsakoff syndrome patients remains stable over two years. J Clin Exp Neuropsychol. 2008 Jul;30(5):576-87. doi: 10.1080/13803390701557271

12. Baddeley AD, Hitch G. Working Memory. In: Bower GH, ed. The Psychology of Learning and Motivation: Advances in Research and Theory, New York: Academic Press; 1974. P. 47-89. doi:10.1016/S0079-7421(08)60452-1

13. Rempel-Clower NL, Zola SM, Squire LR, Amaral DG. Three cases of enduring memory impairment after bilateral damage limited to the hippocampal formation. J Neurosci. 1996 Aug 15;16(16):5233-55. doi: 10.1523/JNEUROSCI.16-16-05233.1996

14. Bonhoeffer K. Der Korsakowsche Symptomenkomplex in seinen Beziehungen zu den verschiedenen Krankheitsformen. Allg Z Psychiat. 1904;61:744-52.

15. Rensen YC, Oosterman JM, Walvoort SJ, et al. Intrusions and provoked and spontaneous confabulations on memory tests in Korsakoff's syndrome. J Clin Exp Neuropsychol. 2017 Mar;39(2):101-11. doi: 10.1080/13803395.2016.1204991

16. Stuss DT, van Reekum R, Murphy K. Differentiation of states and causes of apathy. In: Borod J, ed. Neuropsychology of Emotion. New York: Oxford University Press; 2000. P. 340-63.

17. Gasquoine PG. A Case of Bariatric Surgery-related Wernicke-Korsakoff Syndrome with Persisting Anterograde Amnesia. Arch Clin Neuropsychol. 2017 Aug 1;32(5):610-7. doi: 10.1093/arclin/acx037

18. Montagne B, Kessels RPC, Wester AJ, de Haan EHF. Processing of emotional facial expressions in Korsakoff's syndrome. Cortex. 2006 Jul;42(5):705-10. doi: 10.1016/S0010-9452(08)70408-8

19. Jung YC, Chanraud S, Sullivan EV. Neuroimaging of Wernicke's encephalopathy and Korsakoff's syndrome. Neuropsychol Rev. 2012 Jun;22(2):170-80. doi: 10.1007/s11065-012-9203-4. Epub 2012 May 11.

20. Antunez E, Estruch R, Cardenal C, et al. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR Am J Roentgenol. 1998 Oct;171(4):1131-7. doi: 10.2214/ajr.171.4.9763009

21. Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry. 1986 Apr;49(4):341-5. doi: 10.1136/jnnp.49.4.341

22. Sullivan EV, Pfefferbaum A. Neuroimaging of the Wernicke-Korsakoff syndrome. Alcohol Alcohol. Mar–Apr 2009;44(2):155-65. doi: 10.1093/alcalc/agn103. Epub 2008 Dec 9.

23. Rogawski MA, Wenk GL. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Rev. Fall. 2003;9(3):275-308. doi: 10.1111/j.1527-3458.2003.tb00254.x

24. Levin OS, Vasenina EE The use of Akatinol Memantine in clinical practice. Sovremennaya terapiya v psikhiatrii i nevrologii. 2015;(1):24-33 (In Russ.).

25. Reisberg B, Doody R, Stöffler A, et al; Memantine Study Group. Memantine in moderate-to-severe Alzheimer's disease. N Engl J Med. 2003 Apr 3;348(14):1333-41. doi: 10.1056/NEJMoa013128

26. Orgogozo JM, Rigaud AS, Stöffler A, et al. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke. 2002 Jul;33(7):1834-9. doi: 10.1161/01.str.0000020094.08790.49

27. Parsons CG, Danysz W, Quack G. Memantine is a clinically well tolerated Nmethyl-D-aspartate (NMDA) receptor antagonist – a review of preclinical data. Neuropharmacology. 1999 Jun;38(6):735-67. doi: 10.1016/s0028-3908(99)00019-2

28. Sivolap YuP. Alcohol abuse and related disorders treatment of alcohol dependence. Nevrologiya, neyropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2014;(3):4-9. doi: 10.14412/2074-2711-2014-3- 4-9 (In Russ.).

29. Krupitsky EM, Neznanova O, Masalov D, et al. Effect of memantine on cue-induced alcohol craving in recovering alcohol-dependent patients. Am J Psychiatry. 2007 Mar;164(3):519-23. doi: 10.1176/ajp.2007.164.3.519

30. Sivolap YuP. Damage to the central nervous system and cognitive impairment in alcoholism: systematics and rational treatment. Narcology. 2010;(3):34-7 (In Russ.).

31. Shatsberg AF, DeBattista C. Rukovodstvo po klinicheskoy psikhofarmakologii [Clinical Psychopharmacology Manual]. Eds Smulevich AB, Ivanova SV. 3rd ed. Moscow: MED-press-inform; 2019. 588 p. (In Russ.).


For citation:


Tyuvina N.A., Maksimova T.N., Prokhorova S.V., Vysokova V.O. Use of akatinol memantine for the treatment of Korsakoff's syndrome: a clinical case. Neurology, Neuropsychiatry, Psychosomatics. 2020;12(6):124-130. (In Russ.) https://doi.org/10.14412/2074-2711-2020-6-124-130

Views: 291


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)